Atrium Medical Corporation is facing a new hernia mesh lawsuit, this one from a New York woman alleging serious C-Qur mesh complications. The hernia mesh lawsuit claims problems with the C-Qur mesh forced the plaintiff to undergo revision surgery and caused her to sustain permanent life altering injuries.

Plaintiff Polly M. filed legal action against Atrium Medical Corporation after learning the company many have deliberately downplayed the risk of C-Qur mesh complications. Polly says she opted for the C-Qur mesh product after reviewing the market materials the manufacturing company provided.

Polly had the C-Qur hernia mesh implanted on June 16, 2016, for open repair of an umbilical hernia. However, little more than a year after the implantation procedure, Polly went to the hospital complaining of an abdominal pain.

Diagnostic procedures revealed Polly was suffering from an abdominal wound and abscess, allegedly due to complications with the C-Qur mesh. During the revision surgery, the C-Qur hernia mesh product was removed and purulent drainage was found near the implant site.

Even though the product was removed, Polly allegedly sustained chronic injuries due to the C-Qur mesh complications. Her hernia mesh injuries reportedly caused degenerative change with necrosis and giant cell reaction, which has allegedly caused Polly to experience an overall diminished quality of life.

After learning of the serious C-Qur mesh complications reported by other patients, Polly decided to file legal action against Atrium Medical Corporation.

Overview of C-Qur Mesh Complications

The FDA approved the C-Qur hernia mesh product in March 2006. It was approved through the FDA’s 510(k) process. Through this process, a medical device can achieve quick FDA approval if it proves to work at least on an equivalent level with an already released product.

Like other hernia mesh products, C-Qur is typically prescribed for ventral and inguinal repair but can also be used for reconstructive and traumatic purposes too. With the 510(k)  process, however, the C-Qur did not have to undergo intense preclinical trials to evaluate the severity of potential side effects.

According to Atrium Medical Corporation, the C-Qur hernia mesh utilizes an all natural Omega 3 fatty acid gel coating for smooth hernia repair. Many hernia mesh lawsuits allege many of the C-Qur mesh complications is due to the Omega 3 coating.

The C-Qur mesh complications listed on the product’s label range in severity, from abdominal pain to organ obstruction. Atrium Medical Corporation had the civil obligation of warning Polly and other patients, against any potential C-Qur mesh complications; it is alleged they did no such thing.

Polly states that she never would have opted for the mesh product if she had been aware of the C-Qur mesh complications.

This Hernia Mesh Lawsuit is Case No. 1:17-cv-00222-LM, in the U.S. District Court for the District of New Hampshire.